Hypovolemic POTS: Low Blood Volume as the Root Cause

Hypovolemic POTS — also called low-flow POTS — is characterized by a chronically reduced circulating blood volume that makes the cardiovascular system exquisitely sensitive to the blood pooling that occurs with standing. It is one of the most treatable POTS subtypes when the diagnosis is made correctly, because the primary intervention (volume expansion) directly addresses the root cause.

What Is Blood Volume and Why Does It Matter?

Total blood volume in an adult is approximately 5 liters (70 mL/kg). Blood volume is regulated by the renin-angiotensin-aldosterone system (RAAS), antidiuretic hormone (ADH), and atrial natriuretic peptide (ANP), which together control how much sodium and water the kidneys retain.

When blood volume is low, the heart has less preload (filling volume) to work with. In the upright position, gravity pulls blood into the lower extremities, reducing venous return to the heart further. In a person with normal blood volume, compensatory mechanisms (increased heart rate, vasoconstriction) maintain cardiac output. In hypovolemic POTS, these compensatory mechanisms are overwhelmed — the heart rate surges to maintain output, but the underlying volume deficit means the surge is insufficient to prevent symptoms.

Causes of Low Blood Volume in POTS

Reduced aldosterone activity. Some POTS patients have impaired aldosterone secretion or aldosterone resistance, causing the kidneys to excrete too much sodium and water. This can be measured by checking plasma aldosterone and renin levels.

Increased natriuretic peptides. Some POTS patients have elevated ANP or BNP levels that promote sodium and water excretion, chronically reducing blood volume.

Deconditioning. Prolonged bed rest or inactivity reduces plasma volume. The cardiovascular deconditioning that often accompanies chronic illness creates a vicious cycle: symptoms cause inactivity → inactivity reduces blood volume → reduced blood volume worsens symptoms.

Inadequate sodium and fluid intake. Many patients inadvertently maintain low blood volume by not consuming enough sodium and fluids to compensate for the increased losses common in dysautonomia.

Autonomic neuropathy. Damage to the sympathetic nerves that control venous tone allows excessive blood pooling in the lower extremities, functionally reducing the effective circulating volume.

Diagnosing Hypovolemic POTS

Nuclear medicine blood volume measurement (using radiolabeled albumin or red blood cells) is the gold standard for measuring total blood volume. Studies have found that POTS patients have blood volumes 13–20% below predicted normal values on average, with hypovolemic subtype patients having the most severe deficits.

Plasma renin and aldosterone. Low aldosterone with high renin suggests aldosterone deficiency. Low renin with low aldosterone suggests a central defect in RAAS activation.

Hematocrit and hemoglobin. Chronically low blood volume is often reflected in a relatively high hematocrit (the blood is "concentrated"), though this is not a reliable diagnostic marker.

Response to volume loading. A dramatic improvement in symptoms with IV saline infusion is strongly suggestive of hypovolemic POTS and can serve as both a diagnostic test and a therapeutic intervention.

Treatment

High sodium intake (3,000–10,000 mg/day). Sodium is the primary driver of plasma volume expansion. The Dysautonomia International guidelines recommend 3,000–5,000 mg/day for most POTS patients, with some patients requiring up to 10,000 mg/day under medical supervision.

High fluid intake (2–3 liters/day). Fluid without sodium is rapidly excreted. Sodium and fluid must be consumed together to expand plasma volume effectively.

Fludrocortisone. A synthetic mineralocorticoid that mimics aldosterone, fludrocortisone promotes sodium and water retention by the kidneys, directly expanding blood volume. Starting dose is 0.05–0.1 mg daily. Side effects include hypokalemia (potassium supplementation is often needed), headache, and edema.

Compression garments. Abdominal binders and thigh-high compression stockings reduce venous pooling in the lower extremities, effectively increasing the functional circulating volume.

IV saline infusions. For patients with severe hypovolemic POTS, regular IV saline infusions (typically 1–2 liters of normal saline) can provide dramatic symptom relief. Some patients receive weekly or bi-weekly infusions as part of their ongoing management.

Exercise reconditioning. The CHOP/Levine protocol (recumbent exercise starting with rowing, swimming, or cycling, gradually progressing to upright exercise over 3 months) has been shown to increase plasma volume by 15–20% and significantly improve POTS symptoms in hypovolemic patients.

Desmopressin (DDAVP). In patients with impaired ADH activity, low-dose desmopressin can reduce urinary water losses and help maintain blood volume. Used cautiously due to risk of hyponatremia.